Table 3 Bivariate analysis for sociodemographic and clinical characteristics of study participants on DTG-based ART in Mengo Hospital, Kampala, Uganda, 2022 (n = 341)

Sex

Male

48 (42.5)

65 (57.5)

Reference

Female

27 (11.8)

201 (88.2)

1.53

1.30–1.81

< 0.001

Age

25–49

51 (21.2)

190 (78.8)

Reference

18–24

1 (10.0)

9 (90.0)

1.14

0.92–1.42

0.232

≥ 50

23 (25.6)

67 (74.4)

0.94

0.82–1.08

0.415

Education level

Post primary

54 (26.0)

154 (74.0)

Reference

Primary or less

21 (15.8)

112 (84.2)

1.14

1.02–1.27

0.021

Physical activity

High

38 (23.3)

155 (76.7)

Reference

Low

37 (20.8)

141 (79.2)

0.56

0.92–1.16

0.306

Alcohol Use

No

55 (20.5)

`214 (79.5)

Reference

Yes

20 (27.8)

52 (72.2)

0.91

0.78–1.06

0.224

DTG duration (years)

≥ 2

62 (24.5)

191 (75.5)

Reference

< 2

13 (14.8)

75 (85.2)

1.13

1.01–1.26

0.034

ART duration (years)

< 10

49 (24.1)

154 (75.9)

Reference

≥ 10

26 (28.8)

112 (81.2)

1.07

0.96–1.20

0.237

HIV duration (years)

< 10

43 (24.2)

135 (75.8)

Reference

≥ 10

32 (19.6)

131 (80.4)

1.06

0.95–1.19

0.313

Baseline CD4* (n = 340)

< 200

30 (24.8)

91 (75.2)

Reference

200–499

≥ 500

30 (20.6)

15 (20.3)

116 (79.4)

59 (79.7)

1.08

0.90

0.92–1.25

072–1.12

0.347

0.311

Previous ART regimen

NNRTI based

65 (23.1)

217 (76.9)

Reference

PI based

2 (12.5)

14 (87.5)

1.14

0.93–1.38

0.199

None

8 (18.6)

35 (81.4)

1.06

0.90–1.24

0.483

BMI

normal

43 (29.7)

102 (70.3)

Reference

overweight

19 (20.2)

75 (79.8)

1.13

0.98–1.31

0.093

obese

13 (12.8)

89 (87.2)

1.24

1.09–1.41

0.001

FBG

Normal

72 (22.3)

251 (77.7)

Reference

High

3 (16.7)

15 (83.3)

1.07

0.86–1.33

0.524